S1E29 / A Magic Bullet? Monoclonal Antibodies / James Crowe

Transcript

"In our case, we're trying to transfer an antibody from one person to another. And it's actually a simpler idea because the recipient of an antibody RNA does not have to really respond to it. They just make it, and they have instant immunity." -Dr. James Crowe

In today’s episode, our host Dr. Celine Gounder speaks with Dr. James Crowe, Director of the Vaccine Center at Vanderbilt Medical Center, about the next phase in antibody-based therapies, which is being spearheaded by Dr. Crowe’s lab at Vanderbilt. They are working on a technique to manufacture immunity in a test tube by isolating a single antibody for a disease that can be used to specifically target and fight that disease. They talk about the upcoming clinical trials of monoclonal antibodies for treatment of COVID-19, and how this method differs from convalescent plasma and vaccination. Finally, they discuss the next frontier- how science may soon take us beyond drug treatments and into a realm where our bodies are programmed to defeat a virus before we’ve ever encountered it… a true magic bullet.

This podcast was created by Just Human Productions. We're powered and distributed by Simplecast. We're supported, in part, by listeners like you.

#SARSCoV2 #COVID19 #COVID #coronavirus

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.